Accord Healthcare Launches Sugammadex Injection, Expanding Access to Neuromuscular Blockade Reversal During Surgery

RALEIGH, N.C., Aug. 5, 2026 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the launch of Sugammadex Injection, indicated for the reversal of neuromuscular blockade induced by...